Investors

Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

Key facts:

 

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
News
Dec 7, 2020
YSOPIA Bioscience Announces Enrollment and Treatment of First Volunteers in its Phase 1 Clinical Trial Evaluating Xla1...
> more
Nov 17, 2020
YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional Development Fund |...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
YSOPIA Bioscience

Find out how gut microbes contribute to good sleep. #gutmicrobiome @MNTMedicalNews1 t.co/I9WmtaV6us

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions